- Patients and Families
- About Alpha-1
- Testing for Alpha-1
- ARALAST Therapy
- Insurance Assistance
- Help and Support
Easy Start Sample Program
Baxter is offering Alpha-1 patients (who have not previously used ARALAST) and their physicians the opportunity to receive up to a two-week sample supply for a no-charge trial.
Talk to your physician to see if ARALAST is right for you. Baxter can only fulfill sample requests from a clinician authorized to dispense prescriptions.
You can have confidence in Baxter's...
- Commitment to a reliable supply of ARALAST
- Distribution of ARALAST through Specialized Pharmacy Providers who provide comprehensive in-home care
- Support for the Alpha-1 community through continued AAT deficiency research
- Patient Assistance programs, including Baxter's ARA-ASSIST Program
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Download a print version of this page
Please review the Important Safety Information and the Full Prescribing Information
| To view PDF, you will need Adobe® Acrobat® Reader® software. |

